Nationwide Fund Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-22,000
Closed -$2.01M 3297
2015
Q3
$2.01M Hold
22,000
0.01% 1353
2015
Q2
$2.7M Sell
22,000
-2,900
-12% -$329K 0.01% 1274
2015
Q1
$2.27M Hold
24,900
0.01% 1399
2014
Q4
$1.69M Sell
24,900
-400
-2% -$29.2K 0.01% 1508
2014
Q3
$2.05M Sell
25,300
-1,600
-6% -$142K 0.01% 1426
2014
Q2
$2.89M Hold
26,900
0.01% 1271
2014
Q1
$1.6M Buy
+26,900
New +$1.6M 0.01% 1493

Other funds holding GWPH

Nationwide Fund Advisors's GWPH Position: Q4 2015 in Review

Nationwide Fund Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2015, closing a stake of 22,000 shares — an estimated $2.01M sold.

Nationwide Fund Advisors first reported a position in GWPH in Q1 2014 and held it in 7 quarters. The position peaked at $2.89M in Q2 2014. 105 funds tracked by Wall St. Rank hold GWPH as of Q4 2015.

  • Nationwide Fund Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2015 after selling out during the quarter.
  • Nationwide Fund Advisors sold 22,000 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2015, an estimated $2.01M.
  • Nationwide Fund Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2014 and held it in 7 quarters.
  • Nationwide Fund Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $2.89M in Q2 2014.
  • 105 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2015.

Based on Nationwide Fund Advisors's 13F filing for Q4 2015, filed 29 Jan 2016.